We’re?grateful for the innovative minds of #TeamSpark,?continually pushing the boundaries of gene therapy, and?for the support of our patients, partners, and the?Philadelphia community, which drives us forward.?#Thankful?
Spark Therapeutics, Inc.
生物技术研究
Philadelphia,PA 91,038 位关注者
Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.
关于我们
At Spark? Therapeutics, we believe in a world where no life is limited by disease.?? We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.?? ? Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm.?? ? Join us on a journey through uncharted territory – seeking to bring gene therapy to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine. Spark is a member of the Roche Group.?? ? Know that working at Spark? Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world where no life is limited by disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx.? Spark’s social media sites are monitored from Monday to Friday during normal business hours. Questions or concerns should be directed here: https://sparktx.com/contact-us/.
- 网站
-
https://www.sparktx.com
Spark Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Philadelphia,PA
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Biotechnology和Gene therapy
地点
-
主要
3737 Market Street
Suite 1300
US,PA,Philadelphia,19104
Spark Therapeutics, Inc.员工
-
Jon Hawayek, MBA
Head State Government Affairs
-
John Adams, Jr.
Senior Director, Validation at Spark Therapeutics, Inc. - Critical Thinker and Validation Thought Leader
-
Scott Strahler
CIO | CISO | CISSP, ISSMP, CGRC | Board Member | Strategic IT leader focused on leveraging technology to achieve company goals, maximize business…
-
Sylvia Kurtz
动态
-
Executive Platforms' Biomanufacturing World Summit explores the latest biomanufacturing trends and innovative strategies. This year, members of #TeamSpark are leading discussions, participating on panels and networking with other industry leaders! Christine Sheaffer, Vice President of Manufacturing & Supply, Michael Nuzzolo, Head of Quality Operations, John Adams, Jr., Jr., Senior Director of Validation, and Karen Arneson, Director of External Manufacturing, will join other speakers to discuss the latest biomanufacturing advancements impacting the #GeneTherapy industry. #BMWS24C
-
This month, THRIVE, Spark’s women-focused ERG, brought #TeamSpark members together with over 10,000 attendees at the Pennsylvania Conference for Women, an annual event dedicated to professional and personal growth. It was an inspiring day filled with community, impactful keynote speakers, and open conversations on women’s equity and influence in the workplace! ?? #PennWomen
-
Amy Shillingford, Spark’s Global Head of IT, is speaking at PSPS: Philadelphia Society of People & Strategy’s upcoming panel discussion alongside other #Philadelphia leaders, exploring how cutting-edge technologies, like AI, can enhance HR strategies. To learn more, visit https://lnkd.in/erDYnkhr.
-
Advanced Therapies kicks off today in Philadelphia and #TeamSpark is thrilled to have six team members speaking. Our experts—Chris Stevens, Chief Patient Supply Officer, Kelly K., Head of US Commercial Ocular Gene Therapy, Pedro J Cejas, Head of New Therapeutic Modalities, Jin Wen, Senior Scientist, Analytical Development, Snehal Naik, Head of Regulatory Policy, and Quan Jin, Capsid Engineering Lead—will be joining fellow industry leaders to share insights and innovations in #GeneTherapy. We’re looking forward to these inspiring discussions at #AdvancedTherapiesUSA!?
-
Today, we honor and thank all veterans for their service, courage, and dedication. At Spark, we’re especially proud of Brave, our Employee Resource Group, which provides a supportive space for our veterans and allies to connect, share experiences, and make an impact. Michael Manacchio, RMIC, Facilities Manager, served in the United States Army and reflects on how his veteran experience has impacted his career. #VeteransDay
-
Leorie Beriguete first joined #TeamSpark in 2021 as a QA Document Control Specialist. Since then, he’s taken advantage of Spark’s community outreach initiatives, participating in numerous events throughout the year. At Spark, we take pride in empowering our employees to reach their full potential, both inside and outside our walls! Leo’s dedication to service is one of the many ways we drive positive change in our #Philadelphia communities.
-
Spark is heading to the Advanced Therapies conference right here in our hometown of #Philadelphia! Six members of #TeamSpark, including Chris Stevens, Chief Patient Supply Officer, will be leading key discussions on the #GeneTherapy industry across multiple informative sessions. We look forward to networking with and learning from decision makers from key biotech and pharma companies. #AdvancedTherapiesUSA.?
-
At Spark? Therapeutics, we have worked tirelessly to build a strong foundational gene therapy platform to bring much needed options to patients living with genetic diseases, such as #InheritedRetinalDiseases, or IRDs.?? ? IRDs are often degenerative, leading to severe vision loss or even blindness. We are working hard to study the causes behind these gene variants with the hope of slowing down or stopping the progression of disease.? ? Watch the video to hear more from Kelly K., Head of U.S. Commercial Ocular Gene Therapy at Spark, about our goals to address the gene variants behind these debilitating diseases.
-
Supporting and uplifting community service is vital to creating stronger, healthier communities. This National Make a Difference Day, we’re proud to partner with local nonprofits who create positive change in their communities from the inside out — just like we do with gene therapy. Thank you, #TeamSpark, for dedicating your time and energy to driving real change! #MakeADifferenceDay #Philadelphia